Digital Health Australia

Australia AI Stroke Detection Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia AI Stroke Detection Market Industry Trends and Forecast to 2034: Segmented by (Modality, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.8 Mn Placeholder estimate
Estimate 2025 $5.9 Mn 1.4% of the global market
Projected 2034 $33.2 Mn 464.3% Adds $27.3 Mn over 9 forecast years
CAGR 2025–2034 21.2% Faster than 66% of 100 Digital Health markets here
Key players 5
  • Australia is 1.36% of the global market.
  • In APAC, the largest is China at $32.7 Mn.
  • Fastest growing: India at 23% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$27.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
AI Stroke Detection Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.8 Mn — —
2025 (base) $5.9 Mn +$1.0 Mn —
2026 (forecast) $7.1 Mn +$1.2 Mn +21.2%
2027 (forecast) $8.6 Mn +$1.5 Mn +46.9%
2028 (forecast) $10.5 Mn +$1.8 Mn +78%
2029 (forecast) $12.7 Mn +$2.2 Mn +115.8%
2030 (forecast) $15.4 Mn +$2.7 Mn +161.5%
2031 (forecast) $18.6 Mn +$3.3 Mn +217%
2032 (forecast) $22.6 Mn +$3.9 Mn +284.2%
2033 (forecast) $27.4 Mn +$4.8 Mn +365.6%
2034 (forecast) $33.2 Mn +$5.8 Mn +464.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia AI Stroke Detection Market Analysis at a glance
Market size, 2025$5.9 Mn placeholder estimate
Forecast, 2034$33.2 Mn placeholder estimate
Growth (CAGR), 2025–203421.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsModality and setting (see all)
Key playersViz.ai, RapidAI, Brainomix, Methinks AI, Aidoc (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia AI Stroke Detection Market Analysis Executive Summary

AI stroke detection reads brain scans within minutes and alerts stroke teams so patients get treatment faster.

Key segments of the AI Stroke Detection market include modality (CT, CT Angiography and MRI) and setting (Comprehensive Stroke Centers, Community Hospitals and Mobile Stroke Units).

Bar chart: Australia AI Stroke Detection market size, 2024–2034, placeholder estimates. $4.8 Mn in 2024, $5.9 Mn in 2025 and $33.2 Mn in 2034, 21.2% CAGR.
Australia AI Stroke Detection market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia AI Stroke Detection Market Dynamics

Market Growth Drivers

Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI Stroke Detection market. Health systems are moving from pilots to wider use.

Opportunity

Generative AI, automation of paperwork and AI tools approved as medical devices give the AI Stroke Detection market strong growth, including in emerging health systems.

Market Restraints

Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI Stroke Detection market.

Competitive Landscape for AI Stroke Detection Market in Australia

The AI Stroke Detection market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for AI Stroke Detection Market in Australia

AI Stroke Detection in Australia: rules and payment

Software that counts as a medical device, including some apps, must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA).⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI Stroke Detection market. Government digital health programs in Australia are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in AI Stroke Detection right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

AI Stroke Detection in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the AI Stroke Detection market in Australia?
Placeholder estimate: about $5.9 Mn in 2025, rising to about $33.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the AI Stroke Detection market in Australia growing?
Placeholder estimate: about 21.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the AI Stroke Detection market report cover?
The report splits the market by modality (CT, CT Angiography, MRI, Perfusion) and setting (Comprehensive Stroke Centers, Community Hospitals, Mobile Stroke Units).
Who are the key players in the AI Stroke Detection market?
Key players include Viz.ai, RapidAI, Brainomix, Methinks AI and Aidoc.
What is driving the AI Stroke Detection market?
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI Stroke Detection market. Health systems are moving from pilots to wider use.
Who regulates AI Stroke Detection in Australia?
Software that counts as a medical device, including some apps, must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA). Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on AI Stroke Detection?
PubMed lists 49,614 papers on AI Stroke Detection added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Australia

See all

Related on artificial intelligence and stroke

See the topic